Disposition and metabolism of tenidap in the rat

Drug Metabolism and Disposition

Volumn 25, Issue 2, 1997, Pages 140-148

  Fouda, Hassan G ^a   Avery, Michael J ^b   Dalvie, Deepak ^b   Falkner, Fred C ^b   Melvin, Lawrence S ^b   Ronfeld, Robert A ^b  

^a PFIZER INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; TENIDAP;

ANIMAL EXPERIMENT; ARTICLE; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISPOSITION; DRUG EXCRETION; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BILE; BIOTRANSFORMATION; CARBON RADIOISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROXYLATION; INDOLES; MALE; MASS SPECTROMETRY; RATS;

ANIMALIA;

EID: 0031019931     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. J. D. Sipe, L. M. Bartle, and L. D. Loose: Modification of pro-inflammatory cytokine production by the antirheumatic agents tenidap and naproxen. a possible correlate with clinical acute phase response. J. Immunol. 148, 480-484 (1992).
2. P. A. McNiff, R. Laliberte, L. Svensson, C. J. Pazoles, and C. A. Gabel: Inhibition of cytokine activation processes in vitro by tenidap, a novel antiinflammatory agent. Cytokine 7, 196-208 (1995).
3. G. Wylie: A 24-week study of tenidap vs. diclofenac in rheumatoid arthritis. Rev. Esp. Reum. 20, 142 (1993).
4. F. E. Wilhelm, D. S. Kirby, A. R. Kraska, L. D. Loose, W. R. Shanahan Jr., N. Ting, and E. S. Weiner: Tenidap (TEN) vs piroxicam (PIR) plus hydroxychloroquine (PIR-HCQ) in rheumatoid arthritis (RA): results of a two-year trial. Arthritis Rheum. 37, S336 (1994).
5. D. S. Kirby, L. D. Loose, E. S. Weiner, F. E. Wilhelm, W. R. Shanahan, and N. Ting: Tenidap vs naproxen treatment of rheumatoid arthritis (RA). Arthritis Rheum. 36, S112 (1993).
6. M. J. Avery, D. Y. Mitchell, F. C. Falkner, and H. G. Fouda: Simultaneous determination of tenidap and its stable isotope analog in serum by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. Biol. Mass Spectrom. 21, 353-357 (1992).
7. D. Y. Mitchell, D. L. Farrell, and F. C. Falkner: Pharmacokinetics of tenidap after oral and intravenous administration to rats. Pharmacologist 34, 181 (1992).
8. H. G. Fouda, M. Avery, and K. Navetta: Simultaneous HPLC radioactivity and mass spectrometry monitoring. A drug metabolism application. In Proceedings 41st ASMS Conference on Mass Spectrometry and Allied Topics, San Francisco, CA, May 31-June 4, 1993.
9. H. Fouda, M. Nocerine, R. Schneider, and C. Gedutis: Quantitative analysis by high-performance liquid chromatography atmospheric pressure chemical ionization mass spectrometry: the determination of the renin inhibitor CP-80,794 in human serum. J. Am. Soc. Mass Spectrom. 2, 164-167 (1991).
10. B. P. V. Macrae, P. C. Jones, and J. F. J. Todd: Investigation of the metabolism of felodipine using on line UV diode array detection/atmospheric pressure chemical ionization mass spectrometry as a diagnostic tool. (Rapid Comm.). Biol. Mass Spectrom. 7, 605-609 (1993).
11. R. P. Schneider, J. J. Lynch, J. F. Ericson, and H. G. Fouda: Electrospray ionization mass spectrometry of semduramicin and other polyether ionophores. Anal. Chem. 63, 1789-94 (1991).
12. 14C-tenidap - a novel antiinflammatory agent. J. Labelled Compounds, in press.
13. F. W. Rusek, W. A. Hada, H. G. Fouda, D. K. Dalvie, and L. M. Melvin, Jr.: Synthesis of tenidap metabolites: Tetrahedron, in press.
14. 4 in different buffers by high-performance liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Biomed. Environ. Mass Sprectrom. 19, 434-446 (1990).
15. D. Mansuy, P. M. Dansette, C. Foures, M. Jaouen, G. Moinet, and N. Bayer: Metabolic hydroxylation of the thiophene ring: isolation of 5-hydroxy-tienilic acid as the major urinary metabolite of tienilic acid in man and rat. Biochem. Pharmacol. 33, 1429-1435 (1984).
16. Y. Mori, N. Kuroda, Y. Sakai, F. Yokoya, K. Toyoshi, and S. Baba: Species differences in the metabolism of suprofen in laboratory animals and man. Drug Metab. Disp. 13, 239-245 (1985).
17. T. Nishikawa, O. Nagata, K. Tanbo, T. Yamada, Y. Takahara, H. Kato, and Y. Yamamoto: Absorption, excretion and metabolism of tiquizium bromide in dogs, and relationship between pharmacological effect and plasma levels of unchanged drug. Xenobiotica 15, 1053-1060 (1985)
18. S. Ichihara, Y. Tsuyuki, H Tomisawa, H. Fukazawa, N Nakayama, and M. Tateishi: Metabolism of tenoxicam in rats. Xenobiotica 14, 727-739 (1984).
19. M. K. Shigenaga, B. H. Kim, P. Caldera-Munoz, T Cairns, P. Jacobs III, A. J. Trevor, and N. Castagnoli, Jr.: Liver and lung microsomal metabolism of the tobacco alkaloid β-nicrotyrine. Chem Res. Toxicol. 2, 282-287 (1989).
20. J. K. Faulkner, S. K. Fidgor, A. M. Monro, M. Schach von Wittenau, D. A. Stopher, and B. A. Wood: The comparative metabolism of pyrantel in five species. J. Sci. Food Agric. 23, 79-91 (1972).
21. J. Lindenbaum, D. G. Rund, V. P. Butler Jr, D. Tse-Eng, and J. R. Saha: Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. New Engl. J. Med. 305, 789-794 (1981).
22. B. R. Goldin: Metabolism of drugs and carcinogens. Ann. Med. 22, 43-48 (1990).